Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Current Medical Research and Opinion|March 31, 2017
Demographic and clinical profiles of type 2 diabetes mellitus patients initiating sitagliptin in the real-world settingManjiri Pawaskar, Jinan Liu, Swapnil Rajpathak, et al.Endocrinology, Diabetes & Metabolism|March 1, 2019
Severity of hypoglycaemia and health-related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in EuropeManjiri Pawaskar, Edward A Witt, Samuel S Engel, et al.Expert Review of Pharmacoeconomics & Outcomes Research|August 23, 2018
Factors associated with physicians' decision to discontinue or down-titrate sulfonylureas for type 2 diabetes patientsPedro Laires, Karen Kurtyka, Edward A Witt, et al.Pharmacoepidemiology and Drug Safety|May 8, 2024
Risk of acute pancreatitis among new users of empagliflozin compared to sulfonylureas in patients with type 2 diabetes: A post-authorization safety studySoulmaz Fazeli Farsani, Kristy Iglay, Ling Zhang, et al.Therapeutic Advances in Gastroenterology|February 17, 2022
Risk of bias in non-randomized observational studies assessing the relationship between proton-pump inhibitors and adverse kidney outcomes: a systematic reviewPradeep Rajan, Kristy Iglay, Thomas Rhodes, et al.Current Medical Research and Opinion|September 1, 2020
Level of glycemic control among US type 2 diabetes mellitus patients on dual therapy of metformin and sodium-glucose cotransporter 2 inhibitor: a retrospective database studyDominik Lautsch, Kristy Iglay, Lingfeng Yang, et al.Current Medical Research and Opinion|May 14, 2016
Risk factors associated with treatment discontinuation and down-titration in type 2 diabetes patients treated with sulfonylureasKristy Iglay, Ying Qiu, Chun-Po Steve Fan, et al.Expert Review of Pharmacoeconomics & Outcomes Research|June 28, 2016
Impact of hypoglycemic events and HbA1c level on sulfonylurea discontinuation and down-titrationPedro A Laires, Jackson Tang, Chun Po Steve Fan, et al.Journal of Clinical & Translational Endocrinology|February 26, 2020
Effects of conformance to type 2 diabetes guidelines on health care resource utilization, clinical outcomes, and cost: A retrospective claims analysisRajesh R Mehta, Alison M Edwards, Swapnil Rajpathak, et al.Clinical Lung Cancer|March 29, 2024
QT-Interval Prolongation, Torsades de Pointes, and Heart Failure With EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: Systematic ReviewBilal Khokhar, Beatrice Chiang, Kristy Iglay, et al.Pageof 5